About us
Who we are
Our strategy
How we are funded
Our people
Governance and structure
Reports and statements
Our impact
Suppliers
Our strategy
Our strategy
Neurodegeneration
Respiratory health
Working with us
Support for MRC researchers
Helping charities
Our partners
Available technologies
Advise & Connect: Covid-19
Funding
LifeArc Ventures
Rare disease research funding
Development Gap Fund
Current funding opportunities
Capabilities
Drug discovery
Antibody humanisation
IP management and technology transfer
Diagnostics development
Careers
Working at LifeArc
Our culture
Benefits and rewards
Students and fellows
How to apply
Job vacancies
News
Latest news
Case studies
Reports and publications
Newsletter
Hybridoma
Catch up with the latest news and developments from LifeArc
LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge
Twitter outputted an error:
Invalid or expired token..
Filter by:
All
News Releases
Articles & blogs
Ventures Funding
15 August 2022
Anti-mouse CD147 dom-o monoclonal antibody
15 August 2022
Anti-myosin monoclonal antibody
15 August 2022
Anti-human CD6 domain 3 monoclonal antibody
15 August 2022
Anti-rat thymocyte monoclonal antibody
15 August 2022
Anti-human CD6 domain 3 monoclonal antibody
15 August 2022
Anti-rat MHC Class II RT1D (Ia-E) monoclonal antibody
15 August 2022
Anti-human CD6.1 monoclonal antibody
15 August 2022
Anti-human Polycystin-1 monoclonal Antibody
15 August 2022
Anti-human SIRP beta 1
1
2
…
14
>
My Interest
Academic Scientist
Pharma/Biotech
Medical Charity
MRC Scientist
Research Organisation